Zoldrone Infusion
Zoledronic Acid 5mg/100mL IV Infusion in Pakistan
Zoldrone Infusion
Zoledronic Acid 5mg/100mL IV Infusion
Zoldrone Infusion is a sterile intravenous bisphosphonate formulation containing Zoledronic Acid 5mg/100mL, indicated for the treatment and prevention of various bone-related disorders. It works by inhibiting osteoclast-mediated bone resorption, thereby improving bone strength and reducing the risk of fractures.
Important Notice
Zoldrone is intended for intravenous use only and should be administered under medical supervision in hospital or clinical settings.
Therapeutic Class
Bisphosphonate
Anti-resorptive agent
Pack Size
100mL single-dose vial
Ready-to-use infusion
Composition
Active Ingredient
Zoledronic Acid (as monohydrate) – 5mg
Each 100mL single-dose vial contains 5mg of Zoledronic Acid
Formulation
Sterile intravenous solution
Ready-to-use infusion for IV administration
Key Benefits
Improves Bone Density
Reduces bone loss and improves bone mineral density
Reduces Fracture Risk
Lowers the risk of fractures significantly
Extended Dosing
Long-acting therapy with extended dosing intervals
Controls Bone Resorption
Effective control of pathological bone resorption
Indications / Uses
- Osteoporosis (postmenopausal, male, and glucocorticoid-induced)
- Paget's disease of bone
- Bone metastases and prevention of skeletal-related events
- Hypercalcemia of malignancy
- Disorders associated with increased bone resorption
Dosage & Administration
- For intravenous infusion only
- To be administered by a qualified healthcare professional
- Dosage and infusion duration as prescribed by the physician
- Renal function assessment and adequate hydration recommended prior to infusion
